HF
AZN icon

HRT Financial’s AstraZeneca AZN Stock Holding History

HRT Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.76M Buy
+19,084
New +$3.68M 0.01% 1169
2025
Q4 		– Sell
-85,818
Closed -$13.2M – 3172
2025
Q3 		$13.2M Buy
85,818
+34,706
+68% +$5.25M 0.05% 301
2025
Q2 		$7.14M Sell
51,112
-65,334
-56% -$9.16M 0.03% 404
2025
Q1 		$17.1M Buy
+116,446
New +$16.8M 0.11% 137
2024
Q4 		– Sell
-99,665
Closed -$15.5M – 2432
2024
Q3 		$15.5M Buy
99,665
+33,331
+50% +$5.38M 0.08% 166
2024
Q2 		$10.3M Buy
66,334
+25,183
+61% +$3.79M 0.06% 244
2024
Q1 		$5.58M Sell
41,151
-73,490
-64% -$9.73M 0.03% 236
2023
Q4 		$15.4M Buy
114,641
+105,978
+1,223% +$13.8M 0.11% 104
2023
Q3 		$1.17M Buy
8,663
+2,494
+40% +$341K 0.01% 887
2023
Q2 		$883K Buy
+6,169
New +$908K 0.01% 1022
2022
Q2 		– Sell
-5,746
Closed -$762K – 2919
2022
Q1 		$762K Sell
5,746
-501
-8% -$60.1K 0.01% 1241
2021
Q4 		$727K Sell
6,247
-104,309
-94% -$12.3M ﹤0.01% 1473
2021
Q3 		$13.3M Buy
+110,556
New +$12.9M 0.08% 118
2021
Q2 		– Sell
-22,276
Closed -$2.21M – 2836
2021
Q1 		$2.21M Buy
22,276
+17,532
+370% +$1.76M 0.02% 568
2020
Q4 		$474K Sell
4,744
-86,037
-95% -$9.11M 0.01% 1047
2020
Q3 		$9.95M Buy
+90,781
New +$10.1M 0.29% 61
2019
Q1 		– Sell
-2,734
Closed -$207K – 515
2018
Q4 		$207K Buy
+2,734
New +$213K 0.03% 476
2017
Q4 		– Sell
-3,253
Closed -$220K – 118
2017
Q3 		$220K Buy
+3,253
New +$206K 0.27% 66

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

HRT Financial's AZN Position: Q1 2026 in Review

HRT Financial opened a new position in AstraZeneca (AZN) in Q1 2026: 19,084 shares worth $3.76M. The stake represents 0.01% of the portfolio and ranks #1169 among its holdings. This is a return to the name: HRT Financial previously reported a position in AZN as recently as Q3 2025.

HRT Financial first reported a position in AZN in Q3 2017 and has held it in 18 quarters since. The position peaked at $17.1M in Q1 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • HRT Financial held 19,084 shares of AstraZeneca worth $3.76M as of Q1 2026.
  • AstraZeneca was a new HRT Financial position in Q1 2026.
  • AstraZeneca made up 0.01% of HRT Financial's portfolio in Q1 2026, its #1169 holding.
  • HRT Financial first reported a position in AstraZeneca in Q3 2017 and has held it in 18 quarters since.
  • HRT Financial's AstraZeneca position peaked at $17.1M in Q1 2025.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.